These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 26372034)
1. Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review. Depmann M; Broer SL; van der Schouw YT; Tehrani FR; Eijkemans MJ; Mol BW; Broekmans FJ Menopause; 2016 Feb; 23(2):224-32. PubMed ID: 26372034 [TBL] [Abstract][Full Text] [Related]
2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263 [TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause. Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779 [TBL] [Abstract][Full Text] [Related]
4. Anti-Mullerian hormone - a marker of upcoming menopause or a questionable guesswork? Warzecha D; Szymusik I; Pietrzak B; Wielgos M Neuro Endocrinol Lett; 2017 May; 38(2):75-82. PubMed ID: 28650599 [TBL] [Abstract][Full Text] [Related]
5. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study. Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849 [TBL] [Abstract][Full Text] [Related]
6. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135 [TBL] [Abstract][Full Text] [Related]
7. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Iliodromiti S; Anderson RA; Nelson SM Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055 [TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148 [TBL] [Abstract][Full Text] [Related]
9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility. Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431 [TBL] [Abstract][Full Text] [Related]
10. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population. Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425 [TBL] [Abstract][Full Text] [Related]
11. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Nelson SM; Klein BM; Arce JC Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196 [TBL] [Abstract][Full Text] [Related]
13. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies. Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134 [TBL] [Abstract][Full Text] [Related]
14. Role of AMH in Prediction of Menopause. de Kat AC; Broekmans FJM; Lambalk CB Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304 [TBL] [Abstract][Full Text] [Related]
15. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth. Nelson SM; Fleming R; Gaudoin M; Choi B; Santo-Domingo K; Yao M Fertil Steril; 2015 Aug; 104(2):325-32. PubMed ID: 26003269 [TBL] [Abstract][Full Text] [Related]
16. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages. Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318 [TBL] [Abstract][Full Text] [Related]
18. Antimullerian hormone in cases of different reproductive pathologies. Barbakadze L; Kristasashvili J Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265 [TBL] [Abstract][Full Text] [Related]
19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Tremellen K; Zander-Fox D Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428 [TBL] [Abstract][Full Text] [Related]